In Vitro & In Vivo Diagnostic Substances Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - In Vitro & In Vivo Diagnostic Substances
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-05-20
QDELQuidel Corp /de/Slacik Charles PDirS - Sale$55.19-1,0008,703-10%-$55,190
M
2019-05-13
NEOGNeogen CorpHerbert James LDirS - Sale$59.05-15,000983,857-2%-$885,711
2019-05-20
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$23.89-16,827637,762-3%-$401,940
2019-05-17
NAVBNavidea Biopharmaceuticals, Inc.Rouan Sarah KathrynDirP - Purchase$1.46+3,3508,350+67%+$4,904
2019-05-16
VIVOMeridian Bioscience IncAnderson James M.DirP - Purchase$11.37+5,00016,981+42%+$56,855
2019-05-15
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$24.75-5,00067,467-7%-$123,755
M
2019-05-16
NAVBNavidea Biopharmaceuticals, Inc.Latkin JedCEO, COO, CFOP - Purchase$1.46+2,50011,950+26%+$3,643
2019-05-17
VRMLVermillion, Inc.Beechey Robert HarryCFOP - Purchase$1.26+5,000205,000+3%+$6,292
D
2019-05-13
IDXXIdexx Laboratories Inc /deHenderson Rebecca MDirS - Sale+OE$241.57-8,79018,696-32%-$2,123,422
M
2019-05-13
IMMUImmunomedics IncAvoro Capital Advisors LLCSee RemarksP - Purchase$15.11+750,00036,682,771+2%+$11,328,750
2019-05-13
NAVBNavidea Biopharmaceuticals, Inc.Bruck ClaudineDirP - Purchase$1.90+2,5507,550+51%+$4,855
M
2019-05-13
NAVBNavidea Biopharmaceuticals, Inc.Latkin JedCEO, COO, CFOP - Purchase$1.80+5,4009,450+133%+$9,721
D
2019-05-10
QDELQuidel Corp /de/Buechler Kenneth FDirS - Sale+OE$60.58-2,00247,769-4%-$121,286
2019-05-10
IDXXIdexx Laboratories Inc /deLane MichaelCorporate VPS - Sale$245.41-1,8124,544-29%-$444,683
D
2019-05-10
NEOGNeogen CorpBoehm William TDirS - Sale+OE$60.84-4,00010,479-28%-$243,380
2019-05-13
VIVOMeridian Bioscience IncPhillips DavidDirP - Purchase$11.40+5,00044,107+13%+$57,015
2019-05-08
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$25.22-5,00072,467-6%-$126,116
D
2019-05-08
QTNTQuotient LtdFarrell EdwardPresS - Sale+OE$8.67-22,5002,133-91%-$195,075
D
2019-05-08
QTNTQuotient LtdStackawitz JeremyPresS - Sale+OE$8.67-22,500131,939-15%-$195,075
2019-05-08
VIVOMeridian Bioscience IncKenny John P.CEOP - Purchase$11.49+20,00083,000+32%+$229,744
D
2019-05-06
NEOGNeogen CorpMorrical Terri AVPS - Sale+OE$61.69-7,60037,575-17%-$468,853
2019-05-06
NEOGNeogen CorpHerbert James LDirS - Sale$60.79-5,000676,484-1%-$303,926
2019-05-06
IDXXIdexx Laboratories Inc /deTwigge GiovaniCORPORATE VPS - Sale$250.00-2,01515,195-12%-$503,750
D
2019-05-03
IDXXIdexx Laboratories Inc /deMcKeon Brian PEVP, CFOS - Sale+OE$247.87-7,50447,528-14%-$1,859,999
D
2019-05-03
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$249.03-28,0001,163,916-2%-$6,972,700
2019-05-01
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale$16.05-3,0003,000-50%-$48,155
M
2019-04-30
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$24.11-10,00077,467-11%-$241,056
D
2019-05-01
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$60.13-6,90213,470-34%-$415,016
2019-04-29
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale$24.84-6,908153,313-4%-$171,615
2019-04-29
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale$24.85-11,25068,483-14%-$279,617
2019-05-01
NEOGNeogen CorpParnell Jack CDirS - Sale$60.58-4,00010,439-28%-$242,320
2019-04-29
NEOGNeogen CorpHerbert James LDirS - Sale$60.01-25,000681,484-4%-$1,500,155
2019-04-29
NEOGNeogen CorpParnell Jack CDirS - Sale$60.26-5,00014,439-26%-$301,300
2019-04-26
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$24.86-29,813654,589-4%-$741,074
2019-04-23
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$24.07-5,00087,467-5%-$120,368
M
2019-04-17
NEOGNeogen CorpHerbert James LDirS - Sale$56.09-41,000322,373-11%-$2,299,496
2019-04-16
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$25.26-5,00092,467-5%-$126,298
2019-04-12
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$25.40-15,799684,402-2%-$401,317
D
2019-04-01
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale+OE$16.68-10,600434,538-2%-$176,772
D
2019-04-01
NEOGNeogen CorpParnell Jack CDirS - Sale+OE$56.98-9,88319,439-34%-$563,173
D
2019-03-28
QDELQuidel Corp /de/Russell Edward KeithS.VP, N.A. Commercial OpsS - Sale+OE$64.60-13,0009,598-58%-$839,742
DM
2019-03-27
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$65.64-25,250301,442-8%-$1,657,448
D
2019-03-26
VRMLVermillion, Inc.Burns James SDirP - Purchase$0.00+34,848397,055+10%+$0
2019-03-22
NAVBNavidea Biopharmaceuticals, Inc.Scott John K Jr.10%P - Purchase$0.14+357,14322,464,350+2%+$50,000
D
2019-03-14
QDELQuidel Corp /de/Borkar Ratan SSVP, Intl Comm OperationsS - Sale+OE$68.00-14,54916,193-47%-$989,332
D
2019-03-12
QDELQuidel Corp /de/Buechler Kenneth FDirS - Sale+OE$66.50-9,00047,769-16%-$598,500
2019-03-12
MYGNMyriad Genetics IncMcDade Ralph LPres Myriad RBM, Inc.S - Sale$31.00-1,975122,604-2%-$61,225
2019-03-06
NTLAIntellia Therapeutics, Inc.Schiermeier AndrewEVP, Dev, Corp StrategyP - Purchase$15.72+7,50016,144+87%+$117,875
2019-03-07
VRMLVermillion, Inc.Schreiber DavidDirS - Sale$1.00-30,000137,405-18%-$30,000
2019-03-06
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale$22.77-4,27179,733-5%-$97,238
2019-03-06
LNTHLantheus Holdings, Inc.McHugh JulieDirS - Sale$22.77-2,59517,510-13%-$59,075
2019-03-06
LNTHLantheus Holdings, Inc.Pruden Gary JDirS - Sale$22.77-3,19210,072-24%-$72,672
2019-03-06
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale$22.77-1,789160,221-1%-$40,734
2019-03-06
LNTHLantheus Holdings, Inc.Thrall James HDirS - Sale$22.78-3,5009,764-26%-$79,723
2019-03-06
LNTHLantheus Holdings, Inc.Robertson A FrederickDirS - Sale$22.77-3,93243,062-8%-$89,536
2019-03-04
OXFDOxford Immunotec Global PlcKeiley Elizabeth MSVP, GCS - Sale$17.00-4,10026,928-13%-$69,712
M
2019-03-04
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$23.35-9,294700,201-1%-$216,995
DM
2019-02-26
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$65.77-75,750301,442-20%-$4,981,835
2019-02-27
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale$23.17-2,360162,010-1%-$54,681
2019-02-27
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale$23.10-3,11184,004-4%-$71,870
DM
2019-02-25
QDELQuidel Corp /de/Gibson KarenSVP, IS, Bus. TransformationS - Sale+OE$66.57-16,0005,191-76%-$1,065,058
DM
2019-02-25
IDXXIdexx Laboratories Inc /deStuder JacquelineCVP, Gen. Counsel, SecretaryS - Sale+OE$210.56-2,5294,389-37%-$532,519
2019-02-25
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$24.06-9,456709,495-1%-$227,519
M
2015-02-10
VIVOMeridian Bioscience IncEllingwood Dwight EDirP - Purchase$16.51+5669,547+6%+$9,344
2019-02-20
QDELQuidel Corp /de/Polan Mary Lake Ph DDirS - Sale$70.17-14,4499,207-61%-$1,013,863
DE
2019-02-20
IDXXIdexx Laboratories Inc /deLane MichaelCorporate VPS - Sale+OE$211.58-7366,324-10%-$155,723
2019-02-19
QDELQuidel Corp /de/Bujarski Robert JosephSVP, Bus Dev, GCS - Sale$65.01-15,00029,685-34%-$975,182
D
2019-02-15
IDXXIdexx Laboratories Inc /deStuder JacquelineCVP, Gen. Counsel, SecretaryS - Sale+OE$208.46-11,6005,762-67%-$2,418,116
2019-02-19
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale$16.99-10,000413,469-2%-$169,934
D
2019-02-19
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$62.50-4,80013,470-26%-$300,008
2019-02-15
QDELQuidel Corp /de/Polan Mary Lake Ph DDirS - Sale$65.12-13,77223,656-37%-$896,885
DM
2019-02-14
QDELQuidel Corp /de/Abney Michael Donald Jr.SVP - DistributionS - Sale+OE$65.00-23,5135,428-81%-$1,528,345
D
2019-02-15
IDXXIdexx Laboratories Inc /deLane MichaelCorporate VPS - Sale+OE$208.00-9713,738-21%-$201,968
2019-02-06
NEOGNeogen CorpParnell Jack CDirS - Sale$62.65-5,00012,655-28%-$313,233
2019-02-11
NEOGNeogen CorpHerbert James LDirS - Sale$61.60-10,262363,373-3%-$632,159
2019-02-08
OCXOncocyte CorpBroadwood Partners, L.P.10%P - Purchase$3.75+533,33316,199,679+3%+$1,999,999
2019-02-06
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale$18.06-4,05773,689-5%-$73,269
2019-02-06
IDXXIdexx Laboratories Inc /deTwigge GiovaniCORPORATE VPS - Sale$209.08-99717,693-5%-$208,454
2019-02-05
IDXXIdexx Laboratories Inc /deKingsley Lawrence DDirP - Purchase$208.68+2,4057,403+48%+$501,875
DM
2019-02-05
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$206.53-47,7141,169,322-4%-$9,854,179
2019-01-30
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$16.47-9,564630,782-1%-$157,497
2019-01-31
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale$16.48-7,651144,326-5%-$126,088
2019-01-31
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale$16.56-3,06077,746-4%-$50,677
2019-02-01
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale$14.25-3,0006,000-33%-$42,751
M
2019-01-30
NEOGNeogen CorpHerbert James LDirS - Sale$59.36-49,4001,080,119-4%-$2,932,615
D
2019-01-29
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$55.09-25,250294,313-8%-$1,391,023
D
2019-01-22
NEOGNeogen CorpHerbert James LChairmanS - Sale+OE$60.06-45,3341,866,003-2%-$2,722,582
2019-01-10
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale$14.91-10,000423,469-2%-$149,073
2018-12-21
NYMXNymox Pharmaceutical CorpDanielsen ErikCFOP - Purchase$1.35+6,00020,900+40%+$8,085
2018-12-19
NYMXNymox Pharmaceutical CorpDanielsen ErikCFOP - Purchase$1.54+5,00014,900+51%+$7,711
DM
2018-12-18
IONSIonis Pharmaceuticals IncHougen Elizabeth LSVP, Finance, CFOS - Sale+OE$52.03-4,06314,774-22%-$211,379
2018-12-13
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.72+5,2373,310,5500%+$9,007
2018-12-12
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.71+6,0003,305,3130%+$10,285
DM
2016-03-24
QTNTQuotient LtdHallsworth FrederickDirS - Sale+OE$7.05-7665,0370%-$536
D
2018-12-11
QTNTQuotient LtdHallsworth FrederickDirP - Purchase$6.50+10,00065,037+18%+$65,000
2018-12-11
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.67+5,0003,299,3130%+$8,359
2018-12-10
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.62+7,5003,294,3130%+$12,132
2018-12-07
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.69+7,0003,286,8130%+$11,821
2018-12-07
QTNTQuotient LtdPerceptive Advisors LLC10%P - Purchase$6.50+2,000,00010,789,054+23%+$13,000,000
2018-12-06
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.74+1,4003,279,8130%+$2,436
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top